Ulrike Schroeder

Title: Ulrike Schroeder: Innovator in Drug Targeting Systems

Introduction

Ulrike Schroeder is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of drug delivery systems, particularly through her innovative work with nanoparticles. Her research focuses on enhancing the effectiveness of drug administration by targeting specific sites within the mammalian body.

Latest Patents

Ulrike Schroeder holds a patent for a drug targeting system, which includes a method of its preparation and its use. The patent describes a composition and method of fabrication that utilizes nanoparticles to deliver drugs to specific targets within or on a mammalian body. This invention simplifies the fabrication process by eliminating the need for surfactants, which were previously deemed necessary. The preferred stabilizers for the nanoparticles include Dextran 12,000 or polysorbate 85. The drug/nanoparticle complex can be administered through various routes, such as oral application, injection, or inhalation, allowing for targeted pharmacological action. Notably, experiments have demonstrated the unexpected ability of this complex to cross the blood-brain barrier, showcasing its potential as a universal approach for drug delivery.

Career Highlights

Ulrike Schroeder is associated with Nanodel Technologies GmbH, where she continues to advance her research in drug delivery systems. Her work has garnered attention for its innovative approach and potential applications in medical treatments.

Collaborations

Ulrike collaborates with Bernhard A. Sabel, further enhancing the impact of her research in the field of drug targeting.

Conclusion

Ulrike Schroeder's contributions to drug targeting systems represent a significant advancement in the field of pharmaceuticals. Her innovative approach to using nanoparticles for targeted drug delivery has the potential to revolutionize treatment methods and improve patient outcomes.